Read more
9:32 AM · 23 May 2025

Morning Wrap (23.05.2025)

  • Asian markets gain as Treasury yields retreat, though U.S. fiscal concerns persist. Most regional indices rose Friday despite a volatile week centered on government debt worries. Japan's Nikkei 225 and TOPIX climbed 0.8% each, shrugging off stronger-than-expected inflation data. Chinese markets outperformed weekly with Shanghai Composite up 0.5% for the week and CSI 300 gaining 0.9%, benefiting from tariff deescalation optimism. Hong Kong's Hang Seng rose 0.5% Friday for a 1.1% weekly gain. S&P 500 futures edged higher marginally, though Wall Street faces 1.5-2% weekly losses.

  • Japan's core inflation surges to two-year high at 3.5%, raising BOJ rate hike odds. April core CPI exceeded forecasts, accelerating from 3.2% in March and marking the fastest pace since January 2023. A refined core measure excluding food and energy reached 3.0%, well above the BOJ's 2% target. Strong wage hikes from spring negotiations boosted consumer spending, with food inflation jumping to 7.0%. ING analysts now expect a 25 basis point BOJ rate hike in July, though uncertainty over U.S. tariffs may limit further moves until early 2026.

  • Dollar set for weekly decline amid fiscal deficit fears following narrow House passage of Trump's tax bill. The "One Big Beautiful Bill" is projected to add $3.8 trillion to national debt over a decade, following Moody's recent U.S. credit downgrade. Dollar Index fell 0.3% in Asian hours and faces a 1% weekly drop. Japanese yen strengthened 1.5% for the week as USD/JPY fell 0.4% Friday. Asian currencies broadly gained with South Korean won up 0.5% and Philippine peso rising 0.6%.

  • Oil prices drop for fourth straight session on OPEC+ supply concerns. Brent crude fell 0.5% to $63.53 and WTI declined 0.5% to $60.87, both heading for first weekly decline in three weeks. Bloomberg reported OPEC+ considering 411,000 bpd output increase for July at June 1 meeting. Weekly losses reached 1.9% for Brent and 2.5% for WTI. U.S. crude storage demand has surged to COVID-pandemic levels as traders brace for supply increases. Fifth round of U.S.-Iran nuclear talks scheduled for Rome Friday.

  • Japan-U.S. trade talks intensify with a fourth round planned for May 30. Top negotiator Ryosei Akazawa will return to Washington next week to meet Treasury Secretary Scott Bessent, who couldn't attend Friday's third round with Commerce Secretary Lutnick and Trade Representative Greer. Prime Minister Ishiba held a 45-minute call with Trump discussing tariffs and economic cooperation. Japan maintains demand for complete tariff elimination while facing 10% general duties plus 25% auto tariffs by the July deadline.

  • Major U.S. banks explore joint stablecoin launch to counter crypto competition. JPMorgan Chase, Bank of America, Citigroup, and Wells Fargo are in early discussions alongside Early Warning Services and Clearing House. The initiative awaits GENIUS Act legislation, which passed a key Senate procedural vote this week. Banks aim to leverage stablecoins for faster cross-border payments while preventing deposit base erosion from big tech entrants.

  • Foxconn advances India expansion despite Trump pressure with a $1.5 billion display facility planned for Tamil Nadu. The Apple supplier proceeds with major investments including an approved $450 million chip assembly plant in Uttar Pradesh, as India emerges as an alternative to China manufacturing. Trump recently told CEO Tim Cook "we are not interested in you building in India," calling for U.S. production return. Reports suggest all U.S.-sold iPhones may eventually come from India due to China tariffs.

14 April 2026, 9:34 PM

Daily Summary: U.S. stock indices are climbing following the PPI data

14 April 2026, 6:13 PM

US OPEN: Wall Street Rallies on Soft PPI Data

14 April 2026, 4:30 PM

BREAKING: US PPI comes in weaker than expected. EURUSD gains ground

14 April 2026, 3:47 PM

JP Morgan earnings: Good, but it could have been better

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.